All News #Library
Biotech
Epirium Bio Gains FDA Nod for MF-300 Sarcopenia Trial
27 Jan 2026 //
BUSINESSWIRE
Epirium Bio Announces Phase 1 MF-300 Results in Older Adults
08 Jan 2026 //
BUSINESSWIRE
Epirium Bio Presents Phase 1 MF-300 Muscle Data at AGS Conference
17 Nov 2025 //
BUSINESSWIRE
Epirium Completes Dosing 1st-In-Human Ph1 MF-300 Sarcopenia Trial
21 Jul 2025 //
BUSINESSWIRE
Epirium Bio Presents Preclinical Data on MF-300 at GSA Meeting
13 Nov 2024 //
BUSINESSWIRE

Market Place
Sourcing Support